Abacus dx COSA 2022 Showcase

Abacus dx creates value by connecting innovative global suppliers with Australasian customers. Visit our stand to find out more about our solutions and the latest innovative technologies for oncology diagnostics.

Learn about how molecular diagnostics with rapid turn-around-times can assist in the diagnosis and treatment for melanoma, colorectal cancer, and lung cancer. As well as simple NGS solutions for breast and ovarian cancers, haematological malignancies, and MRD monitoring.

Biocartis is an innovative molecular diagnostics company committed to revolutionise molecular testing with its unique Idylla platform. The Idylla platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in any setting, allowing fast and effective treatment selection.